Maravai LifeSciences Holdings Inc
NASDAQ:MRVI

Watchlist Manager
Maravai LifeSciences Holdings Inc Logo
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Watchlist
Price: 2.045 USD -1.21% Market Closed
Market Cap: 520.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+39%
Revenue
Forecast
+21%
Operating Income
Forecast
+22%
Net Income
Forecast
+19%

Wall Street
Price Targets

MRVI Price Targets Summary
Maravai LifeSciences Holdings Inc

Wall Street analysts forecast MRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRVI is 5.953 USD with a low forecast of 1.515 USD and a high forecast of 13.86 USD.

MRVI Lowest Forecast
Wall Street Target
1.515 USD
26% Downside
MRVI Average Forecast
Wall Street Target
5.953 USD
191% Upside
MRVI Highest Forecast
Wall Street Target
13.86 USD
578% Upside
Lowest
Price Target
1.515 USD
26% Downside
Average
Price Target
5.953 USD
191% Upside
Highest
Price Target
13.86 USD
578% Upside
Maravai LifeSciences Holdings Inc Competitors:
Price Targets
AVTR
Avantor Inc
73% Upside
PIQ
Proteomics International Laboratories Ltd
31% Upside
4880
CellSource Co Ltd
37% Upside
RGEN
Repligen Corp
31% Upside
AVTR
Avantor Inc
73% Upside
PIQ
Proteomics International Laboratories Ltd
31% Upside
4880
CellSource Co Ltd
37% Upside
RGEN
Repligen Corp
31% Upside
CTKB
Cytek Biosciences Inc
81% Upside
G
GENO
Genovis AB
64% Upside
ADPT
Adaptive Biotechnologies Corp
27% Upside
R
301333
R&G PharmaStudies Co Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
Maravai LifeSciences Holdings Inc

For the last 5 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 13%. The projected CAGR for the next 3 years is 1%.

13%
Past Growth
1%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Maravai LifeSciences Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
What are analyst estimates?

See Also

Summary
MRVI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRVI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRVI stock valuation using valuation multiples.
Wall Street Estimates
MRVI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRVI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRVI's stock price target?
Price Target
5.953 USD

According to Wall Street analysts, the average 1-year price target for MRVI is 5.953 USD with a low forecast of 1.515 USD and a high forecast of 13.86 USD.

What is Maravai LifeSciences Holdings Inc's Revenue forecast?
Projected CAGR
1%

For the last 5 years the compound annual growth rate for Maravai LifeSciences Holdings Inc's revenue is 13%. The projected CAGR for the next 3 years is 1%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.